You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to nonalcoholic steatohepatitis, the company said.
13 November 2018 - - US-based immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has advanced its oncology programme, the company said.
Following promising preclinical data presented TODAY at the Society for Immunotherapy ...
Following promising preclinical data presented TODAY at the Society for Immunotherapy ...
13 November 2018 - - US-based biotechnology company Obsidian Therapeutics, Inc has presented preclinical data demonstrating fine-tuned regulation of cytokine production and CAR-T function using Destabilizing Domains paired with FDA-approved small mol...
13 November 2018 - - Analysts at UK-based technology research and advisory company Technavio forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6% during the forecast period, according to their latest m...
13 November 2018 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has priced an offering of USD 210m aggregate principal amount of its 6.25% convertible senior notes due 2023 in a private offering to qualified institutional buyers p...
13 November 2018 - - Japanese drugmaker Eisai Co., Ltd. and US-based Merck (NYSE: MRK) have received results from presentations of new data and analyses of Lenvima (lenvatinib), an orally available kinase inhibitor discovered by Eisai, in combination...
13 November 2018 - - The US Food and Drug Administration has cleared two investigational new drug applications for US-based immuno-oncology biotechnology company Fortis Therapeutics, Inc's lead candidate, FOR46, for the treatment of metastatic c...